CRL (Charles River Laboratories International) Insider Ownership: 3.73 % (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRL Charles River Laboratories International Inc CRL
74 GF Score
Price $280.05
GF Value $194.36
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Charles River Laboratories International Insider Ownership?

Charles River Laboratories International CRL -0.43% 74 Insider Ownership is 3.73 % as of Aug. 16, 2026. GuruFocus rates CRL with a GF Score™ of 74/100 and a GF Value™ of $194.36 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Charles River Laboratories International's insider ownership is 3.73%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Charles River Laboratories International's Institutional Ownership is 119.69%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Charles River Laboratories International's Float Percentage Of Total Shares Outstanding is 86.53%.

Charles River Laboratories International Insider Ownership Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Insider Ownership Chart

Charles River Laboratories International Historical Data

The historical data trend for Charles River Laboratories International can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 3.96 3.96 3.96 3.96 3.97 3.96 3.99 4.19 3.73 3.73
CRL
74GF Score
Charles River Laboratories International Inc CRL
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 3.73 % mean?
Charles River Laboratories International (CRL) has a Insider Ownership of 3.73 % as of Aug. 16, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Insider Ownership too high?
Charles River Laboratories International's current Insider Ownership is 3.73 %. Overall, Charles River Laboratories International has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Insider Ownership compare to RVTY and ICLR?
Charles River Laboratories International's Insider Ownership of 3.73 % can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Diagnostics & Research company?
A good Insider Ownership depends on the Medical Diagnostics & Research industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current Insider Ownership is 3.73 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Based on GuruFocus' analysis, Charles River Laboratories International (CRL) is currently considered Significantly Overvalued. The stock's GF Value™ is $194.36, compared to a current price of $280.05 — trading 44.1% above its estimated fair value. The current Insider Ownership is 3.73 %. Charles River Laboratories International's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Charles River Laboratories International (CRL), the current Insider Ownership is 3.73 % as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of $280.05 is trading 44.1% above its estimated GF Value™ of $194.36. GuruFocus considers Charles River Laboratories International to be Significantly Overvalued.

Key valuation signals for CRL:

  • Insider Ownership: 3.73 %
  • GF Value™: $194.36 vs. price of $280.05 (44.1% above fair value)
  • GF Score™: 74/100 with 9 warning signs

No single metric tells the full story. See the CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charles River Laboratories International Business Description

Other Exchanges RV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
74GF Score

Get the complete analysis for CRL

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$280.05
Price
$194.36
GF Value